117837-77-1 Usage
General Description
4-Cyanobenzamidine Hydrochloride (CAS number 454020-94-9) is primarily used in biochemistry, particularly for protease inhibition. 4-CyanobenzaMidine Hydrochloride, also known as 4-aminobenzone trichloride, may be utilized in various biology and chemistry experiments for research or development purposes. It appears as a crystalline solid, and it’s recommended to be stored in cool, dry, and well-ventilated area away from heat and direct sunlight. While it is not classified as dangerous or hazardous, it's advisable to handle it with suitable protective clothing, gloves and eye/face protection. Detailed safety procedures can usually be found in its Material Safety Data Sheet (MSDS).
Check Digit Verification of cas no
The CAS Registry Mumber 117837-77-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,7,8,3 and 7 respectively; the second part has 2 digits, 7 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 117837-77:
(8*1)+(7*1)+(6*7)+(5*8)+(4*3)+(3*7)+(2*7)+(1*7)=151
151 % 10 = 1
So 117837-77-1 is a valid CAS Registry Number.
117837-77-1Relevant articles and documents
NOVEL AROMATIC HETEROCYCLIC DERIVATIVE, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENT ELEMENT MATERIAL SOLUTION, AND ORGANIC ELECTROLUMINESCENT ELEMENT
-
Paragraph 0449-0451, (2016/10/09)
A novel aromatic heterocyclic derivative has a specific structure in its molecule which combines a hole transporting ability and an electron transporting ability. The aromatic heterocyclic derivative is used in a material for an organic electroluminescenc
5-ETHYLIMIDAROTRIAZONES
-
Page/Page column 28-29, (2010/02/07)
The invention relates to novel 5-ethyl-imidazotriazinones, processes for their preparation and their use in medicaments, esp. for the treatment and/or prophylaxis of inflammatory processes and/or immune diseases.
Sulfonamides
-
, (2008/06/13)
Compounds of the formula: STR1 where A, B, R1 -R8 are as described herein are endothelin inhibitors that can be used in treating diseases associated with endothelin, such as high blood pressure. Chemical synthesis of these compounds and pharmaceutical compositions containing these compounds are also useful.